Work

Recombinant AAT-Fc fusion protein INBRX-101 achieves normal serum AAT levels in patients with alpha-1 antitrypsin deficiency (AATD)

Year: 2022

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2022.3599

Authors: A Veale, H Farah, R Mahadeva, M Baker, B Kuhn, A Cole, C Chang, C Brown, M Campos, J Kalabus, T Boyea, C Veldstra, V Andrianov, S Bhagwat, B P Eckelman, J Loscano, M Brantly

Institutions: NZ Respiratory & Sleep Institute, University of Cambridge, University of California, Davis, Christchurch Clinical Studies Trust, Waikato Hospital, Indiana University Indianapolis, University of Miami, Inhibrx (United States), University of Florida Health, University of Florida

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313178477

Cites:

Cited by: 2

Related to: 10